Free Trial

Centessa Pharmaceuticals (CNTA) SEC Filings & 10K Form

Centessa Pharmaceuticals logo
$13.07 +0.12 (+0.93%)
Closing price 04:00 PM Eastern
Extended Trading
$13.06 -0.01 (-0.08%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Centessa Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/28/2025
8:15 AM
Centessa Pharmaceuticals (Filer)
Form DEFA14A
05/27/2025
5:31 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:44 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:19 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:49 PM
Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:18 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
8:03 AM
Adage Capital Management, L.P. (Filed by)
Centessa Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/06/2025
8:00 AM
Centessa Pharmaceuticals (Filer)
Centessa Pharmaceuticals (Filer)
Form DEF 14A
05/06/2025
8:03 AM
Centessa Pharmaceuticals (Filer)
Form ARS
05/02/2025
3:17 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
3:58 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:09 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2025
7:20 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
4:43 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
3:46 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2025
3:59 PM
Centessa Pharmaceuticals (Filer)
Form PRE 14A
04/21/2025
3:14 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
6:31 AM
Centessa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
6:11 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:53 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:08 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:47 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:47 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:45 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:25 PM
Centessa Pharmaceuticals (Subject)
CHAO DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
4:45 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:59 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:33 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:14 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:08 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
3:04 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

01/27/2025
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
3:16 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:00 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:30 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:33 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:28 PM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
5:10 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:22 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:18 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
4:09 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:10 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:11 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:03 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:03 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:33 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:43 PM
Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:16 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
6:19 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:27 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:15 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q/A
09/27/2024
3:15 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:01 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:55 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:40 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
09/11/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form S-3ASR
09/10/2024
3:04 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:06 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:12 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:13 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:19 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
4:15 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:32 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:13 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

08/21/2024
3:38 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:52 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
6:27 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:15 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:31 PM
Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTA) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners